70 patents
Utility
Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
2 Jan 24
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a JAK inhibitor.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 6 May 21
Utility
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
16 Nov 23
Ingestible devices capable of delivering a dispensable substance, such as, for example, a therapeutic agent, as well as related components, systems and methods, are disclosed.
Mitchell Lawrence Jones, Christopher Loren Wahl, Gene Alan Wey, Aaron Olafur Laurence Philippsen, Mark Sasha Drlik, Ryan Elliott Jones, Nathan John Mueller, Andrew Carlos Garland, Iman Niknia
Filed: 27 Jul 23
Utility
Ingestible device for delivery of a dispensable substance
24 Oct 23
Ingestible devices capable of delivering a dispensable substance, such as, for example, a therapeutic agent, as well as related components, systems and methods, are disclosed.
Mitchell Lawrence Jones, Christopher Loren Wahl, Gene Alan Wey, Aaron Olafur Laurence Philippsen, Mark Sasha Drlik, Ryan Elliott Jones, Nathan John Muller, Andrew Carlos Garland, Iman Niknia
Filed: 3 Apr 20
Utility
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
5 Oct 23
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 31 Oct 22
Utility
Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
25 Jul 23
Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same.
Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Ryan Elliott Jones, Kevin Howe, Pejman Rahimian, Nelson Quintana
Filed: 11 Dec 20
Utility
Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
7 Mar 23
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with IL-10 or an IL-10 agonist.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 30 Mar 18
Utility
Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible device
7 Mar 23
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 14 Dec 17
Utility
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
19 Jan 23
Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same.
Jeffrey A. SHIMIZU, Mitchell Lawrence JONES, Mark Sasha DRLIK, Iman NIKNIA, Nathan John MULLER, Tuyen NGUYEN, Christopher Loren WAHL, Edward MUDGE, Nicholas Mark SALT, Nia Eleri STEVENS, Stuart Robert ABERCROMBIE, Christopher Ian BUNCE, Ryan Elliott JONES, Kevin HOWE, Pejman RAHIMIAN, Nelson QUINTANA
Filed: 15 Sep 22
Utility
Treatment of a Disease of the Gastrointestinal Tract with a TLR Modulator
19 Jan 23
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TLR agonist.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 13 Jul 22
Utility
Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract
10 Jan 23
The present disclosure relates to methods of collecting and testing bacteria containing samples from within the gastrointestinal (GI) tract of a subject.
Sharat Singh, Mitchell Lawrence Jones, Christopher Loren Wahl
Filed: 10 Mar 21
Utility
Treatment of a disease of the gastrointestinal tract with an immunosuppressant
13 Dec 22
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 14 Dec 17
Utility
Ingestible device recovery system
18 Oct 22
Various embodiments are described herein for a recovery tool kit system including a recovery tool and an associated retrieval method for retrieving and storing an ingestible device.
Mitchell Lawrence Jones, Christopher Loren Wahl, Alec John Lillis
Filed: 10 Nov 17
Utility
Localization Systems and Methods for an Ingestible Device
13 Oct 22
Ingestible devices are disclosed that provide very high localization accuracy for the devices when present in the GI tract of a body.
Mitchell Lawrence Jones, Yi Liu, Kate LeeAnn Bechtel, Christopher Loren Wahl
Filed: 23 May 22
Utility
Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
13 Sep 22
A method of treating a disease or condition in a subject in need thereof is disclosed.
Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Nelson Quintana
Filed: 13 May 21
Utility
Ingestible Device and Associated Methods
1 Sep 22
An ingestible device is disclosed which can produce spectral data of one or more analytes, as well as associated methods for characterizing the gastrointestinal tract of a subject which contains such analytes.
Ryan Elliott Jones, Hamilton Roger Tang, Rachel Ellen Gerver, Mitchell Lawrence Jones
Filed: 16 May 22
Utility
Treatment of a disease of the gastrointestinal tract with a TLR modulator
30 Aug 22
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TLR agonist.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 14 Dec 17
Utility
Methods, Systems, and Compositions for Counting Nucleic Acid Molecules
24 Mar 22
Compositions and methods, systems, and kits for detecting and quantifying variations in numbers of molecules, particularly variations in gene dosage, e.g., due to gene duplication, or to variations from the normal euploid complement of chromosomes, e.g., trisomy of one or more chromosomes that are normally found in diploid pairs, without digital sequencing.
Matthew Sekedat, Jeffrey Buis, Ronald David Beaubien, Sharat Singh, Jeff Perry
Filed: 7 Dec 21
Utility
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
10 Mar 22
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.
Mitchell Lawrence Jones, Sharat Singh, Christopher Loren Wahl, Harry Stylli
Filed: 14 Dec 17
Utility
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/chemokine Receptor Inhibitor
10 Mar 22
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor.
Mitchell Lawrence Jones, Christopher Loren Wahl, Sharat Singh, Harry Stylli, Allison Luo
Filed: 8 Mar 21
Utility
Ingestible device with relatively large payload volume
8 Feb 22
Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
Mitchell Lawrence Jones, Russell B. Ford, Edward G. Solomon, Jeffrey A. Shimizu
Filed: 12 Mar 19